(Q33247170)

24 July 2017

Effects of an alpha 2 antagonist in a 20-year-old Java monkey with MPTP-induced parkinsonian signs (English)

1 reference

24 July 2017

Effects of an alpha2 antagonist ina 20-year-old Java monkey with MPTP-induced parkinsonian signs (English)

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

27 October 2022

1 reference

F. C. Colpaert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678307

27 October 2022

A. D. Degryse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678307

27 October 2022

H. V. Van Craenendonck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678307

27 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1678307

27 October 2022

publication date

1 April 1991

1 reference

full work available at URL

24 July 2017

https://api.elsevier.com/content/article/PII:036192309190106T?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

https://api.elsevier.com/content/article/PII:036192309190106T?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

27 October 2022

published in

Brain Research Bulletin

1 reference

24 July 2017

26

1 reference

24 July 2017

4

1 reference

24 July 2017

627-631

1 reference

Norepinephrine-dopamine interactions and behavior

24 July 2017

1

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

27 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

The involvement of noradrenaline in motor activity as shown by rotational behaviour after unilateral lesions of the locus coeruleus

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Clinical effectiveness of reserpine

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Some aspects of the effects of acute reserpine treatment on behaviour

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Clonidine regularizes substantia nigra dopamine cell firing

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (mptp) and its relevance to parkinson's disease

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Use of reserpine in a neuropsychiatric hospital

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Behavioral effects of neuroleptics, apomorphine and amphetamine after bilateral lesion of the locus coeruleus in rats

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Evidence for existence of two opposite noradrenergic brain systems controlling behavior

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

MPTP neurotoxicity: an overview and characterization of phases of toxicity

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

27 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

27 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Assessment of Parkinson's disease.

27 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disea

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Reserpine rigidity and adrenergic neurones

27 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in rats

27 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. III. Evidence for the existence of an alpha 2-adrenergic tonic inhibition in behaving rats.

27 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys

27 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Prevention of reserpine rigidity by alpha-2 adrenergic antagonists

27 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

27 October 2022

Q94271328

37

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization

27 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90106-T

27 October 2022

Identifiers

1 reference

24 July 2017

1 reference